Baxter International Inc. announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate authorizations.
Baxter completes first commercial batches of A/H1N1 vaccine